Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma
Ying Zhu(University of Southern California), Marie C.M. Lin(Shenzhen University)
Cited by 12
Related Papers
An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing Glycolysis
|PLoS Pathogens|2016|75
Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma
|Molecular Medicine Reports|2015|63
The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer
|International Journal of Biological Sciences|2019|35